BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2019
View Archived Issues
Interim phase II data presented for tazemetostat patients with follicular lymphoma
Read More
New BALB/c-hCD3E mouse model for evaluating the therapeutic efficacy of T-cell bispecific Abs
Read More
Results for dose-optimization phase of PRIMO trial of duvelisib in patients with R/R PTCL
Read More
Transplantation with MGTA-456 results in complete engraftment and rapid recovery
Read More
Janssen presents results from phase II trials of JNJ-42165279
Read More
UBA1 as a potent and druggable target in TNBC
Read More
Praxis Precision Medicines patents voltage-gated sodium channel blockers
Read More
Washington University patent describes MAPK inhibitors
Read More
Vanderbilt University reports RAS GTPase inhibitors
Read More
Muscarinic M1 receptor PAMs reported in Vanderbilt University patent
Read More
GABRA5 positive allosteric modulators designed at Roche
Read More
Oral compound ameliorates beta-thalassemia
Read More
By spying on quorum sensing, immune system picks its battles
Read More
China NMPA approves Sinovac's varicella vaccine
Read More
Remimazolam tosylate obtains first approval in China
Read More
Tislelizumab approved in China for classical Hodgkin's lymphoma
Read More
AstraZeneca begins first-in-human study of AZD-0466
Read More
Phase III MOMENTUM trial of AXS-08 for migraine meets coprimary endpoints
Read More
FDA approves Lynparza as first-line maintenance treatment for gBRCAm metastatic pancreatic cancer
Read More
Wave reports topline data from ongoing phase Ib/IIa study of WVE-120102 for Huntington's disease
Read More
Eli Lilly initiates phase III trial with selpercatinib in RET-mutant medullary thyroid cancer
Read More